An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.

Halozyme Therapeutics sees strong Q4 2024 growth, driven by ENHANZE platform royalties. Click here to find out why HALO stock ...

Batoclimab receives Orphan Drug Designation in Japan, advancing treatment for active Thyroid Eye Disease (TED). Batoclimab, ...

As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...

Subcutaneous administration of trastuzumab and pertuzumab significantly shortened the time patients with stage I ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...

All eyes are on Alnylam as the company awaits entry into the transthyretin amyloid cardiomyopathy market, which currently ...

The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...

Many people who have struggled with their weight have been told to “eat less and move more.” Others have spent years juggling ...